The extreme heat of Summer 2026 could disproportionately affect midlife women, especially those undergoing menopause, due to their heightened vulnerability to dehydration. Symptoms such as hot flashes and night sweats exacerbate fluid loss, increasing the risk of dehydration-related complications like fatigue, dizziness, and joint discomfort. Individuals on GLP-1 medications may also face challenges in maintaining hydration due to reduced appetite and fluid intake. Without adequate hydration, the body's ability to regulate temperature and maintain essential functions could be compromised, leading to potential health risks.